Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Developmental Dysplasia of the Hip

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Developmental Dysplasia of the Hip in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Beaulé, PE; Melkus, G; Rakhra, KS; Wilkin, G1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Developmental Dysplasia of the Hip

ArticleYear
What Is the Correlation Among dGEMRIC, T1p, and T2* Quantitative MRI Cartilage Mapping Techniques in Developmental Hip Dysplasia?
    Clinical orthopaedics and related research, 2021, 05-01, Volume: 479, Issue:5

    Topics: Administration, Intravenous; Adult; Cartilage, Articular; Contrast Media; Developmental Dysplasia of the Hip; Female; Heterocyclic Compounds; Hip Joint; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Young Adult

2021